PlainRecalls
FDA Drug Low Class III Terminated

Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.

Reported: April 20, 2022 Initiated: April 5, 2022 #D-0766-2022

Product Description

Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.

Reason for Recall

Subpotent Drug: Out of Specification results for Assay

Details

Recalling Firm
Aurobindo Pharma USA Inc.
Units Affected
433,809 vials
Distribution
Nationwide in the USA.
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.. Recalled by Aurobindo Pharma USA Inc.. Units affected: 433,809 vials.
Why was this product recalled?
Subpotent Drug: Out of Specification results for Assay
Which agency issued this recall?
This recall was issued by the FDA Drug on April 20, 2022. Severity: Low. Recall number: D-0766-2022.